PAVmed Inc. (PAVM) Stock Analysis

Company Overview

PAVmed Inc. (PAVM) is capitalised at $42.22M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 41.

The most recent close on file for PAVM is $5.28, dated September 4, 2026. That is +$0.19 (+3.73%) against the previous close. The 52-week range on file runs from $3.85 to $28.44. The latest close sits 37.14% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $71.00K. That is −97.63% against the prior fiscal year, when revenue was $3.00M. The same year closed with net income of $401.00K. That is −98.99% against the prior fiscal year. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −17.03.

Across the 4 fiscal years on file, revenue moves from $377.00K in 2022 to $71.00K in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 376.95. On price-to-sales that is 126.7 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −60.36%. Across 10 years the annualized return works out at −50.91%. The reported beta is 0.54. Daily returns over the trailing 10 years annualize to a volatility of 98.16%.

Growth & Income

The record shows no dividend for PAVM.

Across the complete calendar years on file, 2020 returned +76.67% and 2024 returned −84.76%. Of the 9 complete calendar years on file, 3 finished higher. 2026 is still running; the price is −20.36% year to date.